Shares of UnitedHealth Group Inc (NYSE:UNH) ended Wednesday session in red amid volatile trading. The shares closed down -0.26 points or -0.19% at $133.69 with 4.59 million shares getting traded. Post opening the session at $133.87, the shares hit an intraday low of $132.98 and an intraday high of $134.69 and the price vacillated in this range throughout the day. The company has a market cap of $125.84 billion and the numbers of outstanding shares have been calculated to be 952.39 million shares.
On August 31, 2016 UnitedHealthcare’s mobile app Health4Me™ now offers several new features including personalized care notifications that automatically alert UnitedHealthcare plan participants about preventive services and if they are missing recommended medical treatments or tests. The app provides a message alert if the user or a covered dependent has missed a recommended medical service, such as an immunization for a child or a blood-sugar test for a diabetic, and enables people to search for health care providers and then schedule appointments to obtain the necessary treatment.
The personalized care notifications are now providing preventive alerts to select UnitedHealthcare plan participants nationwide, including Medicaid beneficiaries in 17 states. Clinically focused notifications based on personalized claims data, such as alerts for prenatal care and support programs for people with back pain, will be introduced later this year. The notifications are based on evidence-based and medical specialty society standards.
As Americans head into open enrollment season, online and mobile resources are becoming increasingly important to help people navigate the health care system and simplify their health care experience. Sixty-five percent of consumers are interested in using a health plan’s website or app to access a physician, and 53 percent are interested in receiving symptom-based treatment suggestions, according to research firm Forrester.
Health4Me is designed to help all consumers make more informed decisions about their care, and anyone can access a guest version of the app to identify local health care providers and comparison shop for care based on quality and cost.
Shares of Endo International plc – Ordinary Shares (NASDAQ:ENDP) ended Wednesday session at $20.34 with 4.58 million shares getting traded. Post opening the session at $20.31, the shares hit an intraday low of $20.21 and an intraday high of $21.21 and the price vacillated in this range throughout the day. The company has a market cap of $4.53 billion and the numbers of outstanding shares have been calculated to be 222.77 million shares.
Endo International plc – Ordinary Shares (ENDP) on Aug. 12, 2016 announced that based on an August 11, 2016 discussion with the U.S. Food and Drug Administration (FDA), the Company has decided to withdraw its supplemental New Drug Application (sNDA) relating to specific abuse deterrent labeling for OPANA® ER without prejudice to re-filing. The Company plans to continue collecting and analyzing epidemiological data relating to OPANA® ER. Endo’s financial projections for 2016 did not assume approval of the sNDA.
“We anticipate the generation of additional data and we will seek collaboration with FDA to appropriately advance OPANA® ER,” said Sue Hall, Ph.D., Executive Vice President, Chief Scientific Officer and Global Head of Research & Development and Quality at Endo. “We believe in the ability of OPANA® ER to continue making a difference in the lives of appropriate patients and remain committed to safely and effectively addressing the needs of the pain patient community.”